CD4+ CD25+ Regulatory T Cells Impair HIV-1-Specific CD4 T Cell Responses by Upregulating Interleukin-10 Production in Monocytes

Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue JVI About JVI Subscribers Authors Reviewers Advertisers Inquiries from...

Full description

Saved in:
Bibliographic Details
Published inJournal of Virology Vol. 86; no. 12; pp. 6586 - 6594
Main Authors Kwon, Douglas S., Angin, Mathieu, Hongo, Tomoyuki, Law, Kenneth M., Johnson, Jessica, Porichis, Filippos, Hart, Meghan G., Pavlik, David F., Tighe, Daniel P., Kavanagh, Daniel G., Streeck, Hendrik, Addo, Marylyn M., Kaufmann, Daniel E.
Format Journal Article
LanguageEnglish
Published Washington, DC American Society for Microbiology 01.06.2012
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue JVI About JVI Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy JVI RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0022-538X Online ISSN: 1098-5514 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to JVI .asm.org, visit: JVI       
AbstractList T cell dysfunction in the presence of ongoing antigen exposure is a cardinal feature of chronic viral infections with persistent high viremia, including HIV-1. Although interleukin-10 (IL-10) has been implicated as an important mediator of this T cell dysfunction, the regulation of IL-10 production in chronic HIV-1 infection remains poorly understood. We demonstrated that IL-10 is elevated in the plasma of individuals with chronic HIV-1 infection and that blockade of IL-10 signaling results in a restoration of HIV-1-specific CD4 T cell proliferation, gamma interferon (IFN-γ) secretion, and, to a lesser extent, IL-2 production. Whereas IL-10 blockade leads to restoration of IFN-γ secretion by HIV-1-specific CD4 T cells in all categories of subjects investigated, significant enhancement of IL-2 production and improved proliferation of CD4 T helper cells are restricted to viremic individuals. In peripheral blood mononuclear cells (PBMCs), this IL-10 is produced primarily by CD14(+) monocytes, but its production is tightly controlled by regulatory T cells (Tregs), which produce little IL-10 directly. When Tregs are depleted from PBMCs of viremic individuals, the effect of the IL-10 signaling blockade is abolished and IL-10 production by monocytes decreases, while the production of proinflammatory cytokines, such as tumor necrosis factor alpha (TNF-α), increases. The regulation of IL-10 by Tregs appears to be mediated primarily by contact or paracrine-dependent mechanisms which involve IL-27. This work describes a novel mechanism by which regulatory T cells control IL-10 production and contribute to dysfunctional HIV-1-specific CD4 T cell help in chronic HIV-1 infection and provides a unique mechanistic insight into the role of regulatory T cells in immune exhaustion.
T cell dysfunction in the presence of ongoing antigen exposure is a cardinal feature of chronic viral infections with persistent high viremia, including HIV-1. Although interleukin-10 (IL-10) has been implicated as an important mediator of this T cell dysfunction, the regulation of IL-10 production in chronic HIV-1 infection remains poorly understood. We demonstrated that IL-10 is elevated in the plasma of individuals with chronic HIV-1 infection and that blockade of IL-10 signaling results in a restoration of HIV-1-specific CD4 T cell proliferation, gamma interferon (IFN- gamma ) secretion, and, to a lesser extent, IL-2 production. Whereas IL-10 blockade leads to restoration of IFN- gamma secretion by HIV-1-specific CD4 T cells in all categories of subjects investigated, significant enhancement of IL-2 production and improved proliferation of CD4 T helper cells are restricted to viremic individuals. In peripheral blood mononuclear cells (PBMCs), this IL-10 is produced primarily by CD14+ monocytes, but its production is tightly controlled by regulatory T cells (Tregs), which produce little IL-10 directly. When Tregs are depleted from PBMCs of viremic individuals, the effect of the IL-10 signaling blockade is abolished and IL-10 production by monocytes decreases, while the production of proinflammatory cytokines, such as tumor necrosis factor alpha (TNF- alpha ), increases. The regulation of IL-10 by Tregs appears to be mediated primarily by contact or paracrine-dependent mechanisms which involve IL-27. This work describes a novel mechanism by which regulatory T cells control IL-10 production and contribute to dysfunctional HIV-1-specific CD4 T cell help in chronic HIV-1 infection and provides a unique mechanistic insight into the role of regulatory T cells in immune exhaustion.
T cell dysfunction in the presence of ongoing antigen exposure is a cardinal feature of chronic viral infections with persistent high viremia, including HIV-1. Although interleukin-10 (IL-10) has been implicated as an important mediator of this T cell dysfunction, the regulation of IL-10 production in chronic HIV-1 infection remains poorly understood. We demonstrated that IL-10 is elevated in the plasma of individuals with chronic HIV-1 infection and that blockade of IL-10 signaling results in a restoration of HIV-1-specific CD4 T cell proliferation, gamma interferon (IFN-γ) secretion, and, to a lesser extent, IL-2 production. Whereas IL-10 blockade leads to restoration of IFN-γ secretion by HIV-1-specific CD4 T cells in all categories of subjects investigated, significant enhancement of IL-2 production and improved proliferation of CD4 T helper cells are restricted to viremic individuals. In peripheral blood mononuclear cells (PBMCs), this IL-10 is produced primarily by CD14(+) monocytes, but its production is tightly controlled by regulatory T cells (Tregs), which produce little IL-10 directly. When Tregs are depleted from PBMCs of viremic individuals, the effect of the IL-10 signaling blockade is abolished and IL-10 production by monocytes decreases, while the production of proinflammatory cytokines, such as tumor necrosis factor alpha (TNF-α), increases. The regulation of IL-10 by Tregs appears to be mediated primarily by contact or paracrine-dependent mechanisms which involve IL-27. This work describes a novel mechanism by which regulatory T cells control IL-10 production and contribute to dysfunctional HIV-1-specific CD4 T cell help in chronic HIV-1 infection and provides a unique mechanistic insight into the role of regulatory T cells in immune exhaustion.T cell dysfunction in the presence of ongoing antigen exposure is a cardinal feature of chronic viral infections with persistent high viremia, including HIV-1. Although interleukin-10 (IL-10) has been implicated as an important mediator of this T cell dysfunction, the regulation of IL-10 production in chronic HIV-1 infection remains poorly understood. We demonstrated that IL-10 is elevated in the plasma of individuals with chronic HIV-1 infection and that blockade of IL-10 signaling results in a restoration of HIV-1-specific CD4 T cell proliferation, gamma interferon (IFN-γ) secretion, and, to a lesser extent, IL-2 production. Whereas IL-10 blockade leads to restoration of IFN-γ secretion by HIV-1-specific CD4 T cells in all categories of subjects investigated, significant enhancement of IL-2 production and improved proliferation of CD4 T helper cells are restricted to viremic individuals. In peripheral blood mononuclear cells (PBMCs), this IL-10 is produced primarily by CD14(+) monocytes, but its production is tightly controlled by regulatory T cells (Tregs), which produce little IL-10 directly. When Tregs are depleted from PBMCs of viremic individuals, the effect of the IL-10 signaling blockade is abolished and IL-10 production by monocytes decreases, while the production of proinflammatory cytokines, such as tumor necrosis factor alpha (TNF-α), increases. The regulation of IL-10 by Tregs appears to be mediated primarily by contact or paracrine-dependent mechanisms which involve IL-27. This work describes a novel mechanism by which regulatory T cells control IL-10 production and contribute to dysfunctional HIV-1-specific CD4 T cell help in chronic HIV-1 infection and provides a unique mechanistic insight into the role of regulatory T cells in immune exhaustion.
T cell dysfunction in the presence of ongoing antigen exposure is a cardinal feature of chronic viral infections with persistent high viremia, including HIV-1. Although interleukin-10 (IL-10) has been implicated as an important mediator of this T cell dysfunction, the regulation of IL-10 production in chronic HIV-1 infection remains poorly understood. We demonstrated that IL-10 is elevated in the plasma of individuals with chronic HIV-1 infection and that blockade of IL-10 signaling results in a restoration of HIV-1-specific CD4 T cell proliferation, gamma interferon (IFN-γ) secretion, and, to a lesser extent, IL-2 production. Whereas IL-10 blockade leads to restoration of IFN-γ secretion by HIV-1-specific CD4 T cells in all categories of subjects investigated, significant enhancement of IL-2 production and improved proliferation of CD4 T helper cells are restricted to viremic individuals. In peripheral blood mononuclear cells (PBMCs), this IL-10 is produced primarily by CD14 + monocytes, but its production is tightly controlled by regulatory T cells (Tregs), which produce little IL-10 directly. When Tregs are depleted from PBMCs of viremic individuals, the effect of the IL-10 signaling blockade is abolished and IL-10 production by monocytes decreases, while the production of proinflammatory cytokines, such as tumor necrosis factor alpha (TNF-α), increases. The regulation of IL-10 by Tregs appears to be mediated primarily by contact or paracrine-dependent mechanisms which involve IL-27. This work describes a novel mechanism by which regulatory T cells control IL-10 production and contribute to dysfunctional HIV-1-specific CD4 T cell help in chronic HIV-1 infection and provides a unique mechanistic insight into the role of regulatory T cells in immune exhaustion.
Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue JVI About JVI Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy JVI RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0022-538X Online ISSN: 1098-5514 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to JVI .asm.org, visit: JVI       
Author Daniel G. Kavanagh
Filippos Porichis
Mathieu Angin
Kenneth M. Law
Daniel E. Kaufmann
Daniel P. Tighe
David F. Pavlik
Marylyn M. Addo
Jessica Johnson
Meghan G. Hart
Hendrik Streeck
Tomoyuki Hongo
Douglas S. Kwon
Author_xml – sequence: 1
  givenname: Douglas S.
  surname: Kwon
  fullname: Kwon, Douglas S.
  organization: Ragon Institute of MGH, MIT and Harvard, Charlestown, Massachusetts, USA, Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA
– sequence: 2
  givenname: Mathieu
  surname: Angin
  fullname: Angin, Mathieu
  organization: Ragon Institute of MGH, MIT and Harvard, Charlestown, Massachusetts, USA
– sequence: 3
  givenname: Tomoyuki
  surname: Hongo
  fullname: Hongo, Tomoyuki
  organization: Ragon Institute of MGH, MIT and Harvard, Charlestown, Massachusetts, USA
– sequence: 4
  givenname: Kenneth M.
  surname: Law
  fullname: Law, Kenneth M.
  organization: Ragon Institute of MGH, MIT and Harvard, Charlestown, Massachusetts, USA
– sequence: 5
  givenname: Jessica
  surname: Johnson
  fullname: Johnson, Jessica
  organization: Ragon Institute of MGH, MIT and Harvard, Charlestown, Massachusetts, USA
– sequence: 6
  givenname: Filippos
  surname: Porichis
  fullname: Porichis, Filippos
  organization: Ragon Institute of MGH, MIT and Harvard, Charlestown, Massachusetts, USA
– sequence: 7
  givenname: Meghan G.
  surname: Hart
  fullname: Hart, Meghan G.
  organization: Ragon Institute of MGH, MIT and Harvard, Charlestown, Massachusetts, USA
– sequence: 8
  givenname: David F.
  surname: Pavlik
  fullname: Pavlik, David F.
  organization: Ragon Institute of MGH, MIT and Harvard, Charlestown, Massachusetts, USA
– sequence: 9
  givenname: Daniel P.
  surname: Tighe
  fullname: Tighe, Daniel P.
  organization: Ragon Institute of MGH, MIT and Harvard, Charlestown, Massachusetts, USA
– sequence: 10
  givenname: Daniel G.
  surname: Kavanagh
  fullname: Kavanagh, Daniel G.
  organization: Ragon Institute of MGH, MIT and Harvard, Charlestown, Massachusetts, USA
– sequence: 11
  givenname: Hendrik
  surname: Streeck
  fullname: Streeck, Hendrik
  organization: Ragon Institute of MGH, MIT and Harvard, Charlestown, Massachusetts, USA
– sequence: 12
  givenname: Marylyn M.
  surname: Addo
  fullname: Addo, Marylyn M.
  organization: Ragon Institute of MGH, MIT and Harvard, Charlestown, Massachusetts, USA, Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA
– sequence: 13
  givenname: Daniel E.
  surname: Kaufmann
  fullname: Kaufmann, Daniel E.
  organization: Ragon Institute of MGH, MIT and Harvard, Charlestown, Massachusetts, USA, Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=26020120$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/22496237$$D View this record in MEDLINE/PubMed
BookMark eNqFkttrFDEYxYNU7Lb65rMEQRDq1Hy5zcyLIFO1KxVF2-JbyGYzu2lnkzGZqeyT_7pZd-sNxKcQ8jsn3-UcoD0fvEXoIZBjAFo9f3s5PSaSCigA7qAJkLoqhAC-hyaEUFoIVn3eRwcpXRECnEt-D-1TymtJWTlB35oTfoSbEyqO8Ee7GDs9hLjG57ixXZfwdNVrF_Hp9LKA4lNvjWudyTjfEVmT-uCTTXi2xhd93Fo4v8BTP9jY2fHa-QII_hDDfDSDCx47j98FH8x6sOk-utvqLtkHu_MQXbx-dd6cFmfv30ybl2eF4SUfioqbqmZGz0sxg4oJCsSUesYs1USwWrStbOe2mpXEQO5aMEpqzURlxLwVtmzZIXqx9e3H2crOjfVD1J3qo1vpuFZBO_Xni3dLtQg3irGaCQ7Z4OnOIIYvo02DWrlk8gi0t2FMCgAYpcAp_T9KQMqSULlxffR7WT_ruV1QBp7sAJ2M7tqovXHpFycJJUBJ5uiWMzGkFG2rjBv0Zty5G9flP9UmLSqnRf1IS75m0bO_RLe-_8Afb_GlWyy_umiVTit1deNUJRVQJUUl2XfRy8jd
CitedBy_id crossref_primary_10_1016_j_cytogfr_2012_05_005
crossref_primary_10_1097_COH_0000000000000093
crossref_primary_10_3390_v6083311
crossref_primary_10_4236_wja_2012_23029
crossref_primary_10_1016_j_virol_2020_05_001
crossref_primary_10_1128_JVI_02034_13
crossref_primary_10_3923_rji_2018_1_6
crossref_primary_10_1172_JCI155251
crossref_primary_10_1016_j_cytogfr_2013_07_001
crossref_primary_10_1089_aid_2014_0356
crossref_primary_10_1186_s12929_019_0604_z
crossref_primary_10_1128_JVI_01186_18
crossref_primary_10_1146_annurev_med_092112_152941
crossref_primary_10_1002_eji_201343646
crossref_primary_10_1186_1471_2334_14_125
crossref_primary_10_1093_infdis_jiw146
crossref_primary_10_1097_QAI_0000000000000095
crossref_primary_10_1038_srep31157
crossref_primary_10_1097_QAD_0000000000000437
crossref_primary_10_7759_cureus_66234
crossref_primary_10_1007_s00203_023_03623_8
crossref_primary_10_1038_s41541_017_0014_8
crossref_primary_10_1093_infdis_jit469
crossref_primary_10_3389_fimmu_2018_02862
crossref_primary_10_3389_fimmu_2019_02849
crossref_primary_10_1089_vim_2015_0066
crossref_primary_10_3389_fimmu_2024_1395921
crossref_primary_10_6061_clinics_2017_11_02
crossref_primary_10_1182_blood_2012_07_409755
crossref_primary_10_3389_fimmu_2014_00090
Cites_doi 10.4049/jimmunol.1002041
10.1016/S0165-2478(01)00275-9
10.4049/jimmunol.158.5.2259
10.1016/S1074-7613(02)00324-2
10.4049/jimmunol.0804024
10.4049/jimmunol.180.5.2752
10.1038/nri2711
10.1073/pnas.97.26.14467
10.1074/jbc.M110.112599
10.1111/j.1572-0241.2002.05926.x
10.4049/jimmunol.180.9.5771
10.1084/jem.174.4.915
10.1016/j.coi.2007.06.004
10.1016/j.tim.2007.02.006
10.4049/jimmunol.178.5.3265
10.4049/jimmunol.166.6.4244
10.4049/jimmunol.153.7.3135
10.1371/journal.pone.0008194
10.1084/jem.187.3.439
10.1126/science.8023143
10.1038/nm.2106
10.1189/jlb.0610327
10.1007/s11904-008-0003-7
10.4049/jimmunol.176.2.1274
10.1016/j.cell.2009.06.036
10.1097/QAD.0b013e3282f153ed
10.1111/j.0105-2896.2006.00412.x
10.4049/jimmunol.165.1.292
10.4049/jimmunol.151.10.5425
10.1086/600072
10.1128/JVI.77.8.4911-4927.2003
10.1074/jbc.M709657200
10.1046/j.1365-2249.1999.00865.x
10.1182/blood-2008-12-191296
10.1371/journal.ppat.1000004
10.1182/blood-2004-01-0365
10.1038/nm1492
10.1196/annals.1313.011
10.1038/ni1515
10.1038/ni1540
10.4049/jimmunol.0803771
10.4049/jimmunol.162.5.2457
10.1084/jem.20061462
10.1007/s00251-003-0594-5
10.1182/blood-2002-10-3065
ContentType Journal Article
Copyright 2015 INIST-CNRS
Copyright © 2012, American Society for Microbiology. All Rights Reserved. 2012 American Society for Microbiology
Copyright_xml – notice: 2015 INIST-CNRS
– notice: Copyright © 2012, American Society for Microbiology. All Rights Reserved. 2012 American Society for Microbiology
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7T5
7U9
H94
5PM
DOI 10.1128/JVI.06251-11
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Immunology Abstracts
Virology and AIDS Abstracts
AIDS and Cancer Research Abstracts
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
AIDS and Cancer Research Abstracts
Immunology Abstracts
Virology and AIDS Abstracts
DatabaseTitleList MEDLINE
AIDS and Cancer Research Abstracts
MEDLINE - Academic


CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1098-5514
EndPage 6594
ExternalDocumentID PMC3393541
22496237
26020120
10_1128_JVI_06251_11
jvi_86_12_6586
Genre Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIAID NIH HHS
  grantid: K08 AI074405
– fundername: NIAID NIH HHS
  grantid: NIH P30 AI060354
– fundername: NIAID NIH HHS
  grantid: 1K08 AI084546-01
– fundername: NIAID NIH HHS
  grantid: R56 AI095088
– fundername: NIAID NIH HHS
  grantid: P01AI-080192
– fundername: NIAID NIH HHS
  grantid: R21 AI083133
– fundername: NIAID NIH HHS
  grantid: P01 AI080192
– fundername: NIAID NIH HHS
  grantid: K08 AI084546
– fundername: NHLBI NIH HHS
  grantid: R01 HL092565
– fundername: NIAID NIH HHS
  grantid: P30 AI060354
GroupedDBID ---
-~X
0R~
18M
29L
2WC
39C
4.4
53G
5GY
5RE
5VS
85S
AAFWJ
AAGFI
AAYXX
ABPPZ
ACGFO
ACNCT
ADBBV
AENEX
AGVNZ
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BTFSW
CITATION
CS3
DIK
E3Z
EBS
EJD
F5P
FRP
GX1
H13
HYE
HZ~
IH2
KQ8
N9A
O9-
OK1
P2P
RHI
RNS
RPM
RSF
TR2
UPT
W2D
W8F
WH7
WOQ
YQT
~02
~KM
.55
.GJ
3O-
41~
6TJ
AAYJJ
ADXHL
AFFNX
AI.
C1A
D0S
IQODW
MVM
OHT
VH1
X7M
Y6R
ZGI
ZXP
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7T5
7U9
H94
5PM
ID FETCH-LOGICAL-c474t-84c893cad75b1835210c7ab3e2a05395ff6fde8b70c100253209a358c5df5e7f3
ISSN 0022-538X
1098-5514
IngestDate Thu Aug 21 18:26:55 EDT 2025
Fri Jul 11 04:23:15 EDT 2025
Fri Jul 11 10:43:37 EDT 2025
Mon Jul 21 05:18:21 EDT 2025
Mon Jul 21 09:12:55 EDT 2025
Tue Jul 01 01:02:14 EDT 2025
Thu Apr 24 23:12:18 EDT 2025
Wed May 18 15:26:08 EDT 2016
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 12
Keywords Virus
CD4 T lymphocyte
Monocyte
HIV-1 virus
Cytokine
Interleukin 10
Retroviridae
Cellular immunity
Human immunodeficiency virus
Lentivirus
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c474t-84c893cad75b1835210c7ab3e2a05395ff6fde8b70c100253209a358c5df5e7f3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
OpenAccessLink https://jvi.asm.org/content/jvi/86/12/6586.full.pdf
PMID 22496237
PQID 1016670261
PQPubID 23479
PageCount 9
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3393541
crossref_citationtrail_10_1128_JVI_06251_11
pubmed_primary_22496237
crossref_primary_10_1128_JVI_06251_11
proquest_miscellaneous_1016670261
pascalfrancis_primary_26020120
highwire_asm_jvi_86_12_6586
proquest_miscellaneous_1113221422
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2012-06-01
PublicationDateYYYYMMDD 2012-06-01
PublicationDate_xml – month: 06
  year: 2012
  text: 2012-06-01
  day: 01
PublicationDecade 2010
PublicationPlace Washington, DC
PublicationPlace_xml – name: Washington, DC
– name: United States
– name: 1752 N St., N.W., Washington, DC
PublicationTitle Journal of Virology
PublicationTitleAlternate J Virol
PublicationYear 2012
Publisher American Society for Microbiology
Publisher_xml – name: American Society for Microbiology
References Kwon DS (e_1_3_3_29_2) 2010; 21
Kishore R (e_1_3_3_27_2) 1999; 162
Dai WJ (e_1_3_3_11_2) 1997; 158
e_1_3_3_17_2
e_1_3_3_16_2
e_1_3_3_19_2
e_1_3_3_38_2
e_1_3_3_18_2
e_1_3_3_39_2
e_1_3_3_13_2
e_1_3_3_36_2
e_1_3_3_37_2
e_1_3_3_15_2
e_1_3_3_14_2
e_1_3_3_35_2
e_1_3_3_32_2
e_1_3_3_33_2
e_1_3_3_30_2
e_1_3_3_10_2
e_1_3_3_31_2
e_1_3_3_40_2
Denis M (e_1_3_3_12_2) 1993; 151
Reed SG (e_1_3_3_34_2) 1994; 153
e_1_3_3_6_2
e_1_3_3_5_2
e_1_3_3_8_2
e_1_3_3_7_2
e_1_3_3_28_2
e_1_3_3_9_2
e_1_3_3_24_2
e_1_3_3_47_2
e_1_3_3_23_2
e_1_3_3_26_2
e_1_3_3_45_2
e_1_3_3_25_2
e_1_3_3_46_2
e_1_3_3_2_2
e_1_3_3_20_2
e_1_3_3_43_2
e_1_3_3_44_2
e_1_3_3_4_2
e_1_3_3_22_2
e_1_3_3_41_2
e_1_3_3_3_2
e_1_3_3_21_2
e_1_3_3_42_2
9036973 - J Immunol. 1997 Mar 1;158(5):2259-67
18424693 - J Immunol. 2008 May 1;180(9):5771-7
20732847 - Eur Cytokine Netw. 2010 Sep;21(3):208-14
12190181 - Am J Gastroenterol. 2002 Aug;97(8):2086-92
12942209 - Immunogenetics. 2003 Sep;55(6):362-9
8023143 - Science. 1994 Jul 8;265(5169):248-52
17906628 - Nat Immunol. 2007 Nov;8(11):1246-54
10209514 - Clin Exp Immunol. 1999 Apr;116(1):115-20
9449724 - J Exp Med. 1998 Feb 2;187(3):439-44
11121048 - Proc Natl Acad Sci U S A. 2000 Dec 19;97(26):14467-72
1655948 - J Exp Med. 1991 Oct 1;174(4):915-24
8089491 - J Immunol. 1994 Oct 1;153(7):3135-40
21041726 - J Immunol. 2010 Dec 1;185(11):6599-607
20519510 - J Biol Chem. 2010 Aug 6;285(32):24404-11
11595300 - Immunol Lett. 2001 Nov 1;79(1-2):131-40
16903920 - Immunol Rev. 2006 Aug;212:272-86
17030951 - J Exp Med. 2006 Oct 30;203(11):2461-72
11238678 - J Immunol. 2001 Mar 15;166(6):4244-53
18090276 - AIDS. 2007 Nov 12;21(17):2283-91
18292493 - J Immunol. 2008 Mar 1;180(5):2752-6
20154735 - Nat Rev Immunol. 2010 Mar;10(3):170-81
8228235 - J Immunol. 1993 Nov 15;151(10):5425-30
12663797 - J Virol. 2003 Apr;77(8):4911-27
19365081 - Blood. 2009 Jul 9;114(2):346-56
17656078 - Curr Opin Immunol. 2007 Aug;19(4):408-15
20208540 - Nat Med. 2010 Apr;16(4):452-9
19414738 - J Immunol. 2009 May 15;182(10):5891-7
19534595 - J Infect Dis. 2009 Aug 1;200(3):448-52
15271794 - Blood. 2004 Nov 15;104(10):3249-56
12468426 - Blood. 2003 Apr 1;101(7):2514-20
17041596 - Nat Med. 2006 Nov;12(11):1301-9
21097698 - J Leukoc Biol. 2011 Apr;89(4):507-15
17994023 - Nat Immunol. 2007 Dec;8(12):1372-9
10861064 - J Immunol. 2000 Jul 1;165(1):292-6
17312176 - J Immunol. 2007 Mar 1;178(5):3265-71
20016783 - PLoS One. 2009;4(12):e8194
16394019 - J Immunol. 2006 Jan 15;176(2):1274-80
16014524 - Ann N Y Acad Sci. 2005 Jun;1050:97-107
18417030 - Curr HIV/AIDS Rep. 2008 Feb;5(1):13-9
18256032 - J Biol Chem. 2008 Apr 25;283(17):11689-99
19748991 - J Immunol. 2009 Oct 1;183(7):4619-27
12121660 - Immunity. 2002 Jun;16(6):779-90
10072482 - J Immunol. 1999 Mar 1;162(5):2457-61
19596234 - Cell. 2009 Jul 10;138(1):30-50
18401464 - PLoS Pathog. 2008 Feb;4(2):e1000004
17336072 - Trends Microbiol. 2007 Apr;15(4):143-6
References_xml – ident: e_1_3_3_23_2
  doi: 10.4049/jimmunol.1002041
– ident: e_1_3_3_8_2
  doi: 10.1016/S0165-2478(01)00275-9
– volume: 158
  start-page: 2259
  year: 1997
  ident: e_1_3_3_11_2
  article-title: Both innate and acquired immunity to Listeria monocytogenes infection are increased in IL-10-deficient mice
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.158.5.2259
– ident: e_1_3_3_32_2
  doi: 10.1016/S1074-7613(02)00324-2
– ident: e_1_3_3_3_2
  doi: 10.4049/jimmunol.0804024
– ident: e_1_3_3_4_2
  doi: 10.4049/jimmunol.180.5.2752
– ident: e_1_3_3_38_2
  doi: 10.1038/nri2711
– ident: e_1_3_3_40_2
  doi: 10.1073/pnas.97.26.14467
– ident: e_1_3_3_22_2
  doi: 10.1074/jbc.M110.112599
– ident: e_1_3_3_30_2
  doi: 10.1111/j.1572-0241.2002.05926.x
– ident: e_1_3_3_9_2
  doi: 10.4049/jimmunol.180.9.5771
– ident: e_1_3_3_13_2
  doi: 10.1084/jem.174.4.915
– ident: e_1_3_3_39_2
  doi: 10.1016/j.coi.2007.06.004
– ident: e_1_3_3_5_2
  doi: 10.1016/j.tim.2007.02.006
– ident: e_1_3_3_18_2
  doi: 10.4049/jimmunol.178.5.3265
– ident: e_1_3_3_2_2
  doi: 10.4049/jimmunol.166.6.4244
– volume: 21
  start-page: 208
  year: 2010
  ident: e_1_3_3_29_2
  article-title: Protective and detrimental roles of IL-10 in HIV pathogenesis
  publication-title: Eur. Cytokine Netw.
– volume: 153
  start-page: 3135
  year: 1994
  ident: e_1_3_3_34_2
  article-title: IL-10 mediates susceptibility to Trypanosoma cruzi infection
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.153.7.3135
– ident: e_1_3_3_17_2
  doi: 10.1371/journal.pone.0008194
– ident: e_1_3_3_41_2
  doi: 10.1084/jem.187.3.439
– ident: e_1_3_3_21_2
  doi: 10.1126/science.8023143
– ident: e_1_3_3_37_2
  doi: 10.1038/nm.2106
– ident: e_1_3_3_35_2
  doi: 10.1189/jlb.0610327
– ident: e_1_3_3_15_2
  doi: 10.1007/s11904-008-0003-7
– ident: e_1_3_3_16_2
  doi: 10.4049/jimmunol.176.2.1274
– ident: e_1_3_3_45_2
  doi: 10.1016/j.cell.2009.06.036
– ident: e_1_3_3_19_2
  doi: 10.1097/QAD.0b013e3282f153ed
– ident: e_1_3_3_36_2
  doi: 10.1111/j.0105-2896.2006.00412.x
– ident: e_1_3_3_33_2
  doi: 10.4049/jimmunol.165.1.292
– volume: 151
  start-page: 5425
  year: 1993
  ident: e_1_3_3_12_2
  article-title: IL-10 neutralization augments mouse resistance to systemic Mycobacterium avium infections
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.151.10.5425
– ident: e_1_3_3_31_2
  doi: 10.1086/600072
– ident: e_1_3_3_47_2
  doi: 10.1128/JVI.77.8.4911-4927.2003
– ident: e_1_3_3_42_2
  doi: 10.1074/jbc.M709657200
– ident: e_1_3_3_43_2
  doi: 10.1046/j.1365-2249.1999.00865.x
– ident: e_1_3_3_6_2
  doi: 10.1182/blood-2008-12-191296
– ident: e_1_3_3_10_2
  doi: 10.1371/journal.ppat.1000004
– ident: e_1_3_3_46_2
  doi: 10.1182/blood-2004-01-0365
– ident: e_1_3_3_7_2
  doi: 10.1038/nm1492
– ident: e_1_3_3_24_2
  doi: 10.1196/annals.1313.011
– ident: e_1_3_3_25_2
  doi: 10.1038/ni1515
– ident: e_1_3_3_20_2
  doi: 10.1038/ni1540
– ident: e_1_3_3_26_2
  doi: 10.4049/jimmunol.0803771
– volume: 162
  start-page: 2457
  year: 1999
  ident: e_1_3_3_27_2
  article-title: Cutting edge: clustered AU-rich elements are the target of IL-10-mediated mRNA destabilization in mouse macrophages
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.162.5.2457
– ident: e_1_3_3_14_2
  doi: 10.1084/jem.20061462
– ident: e_1_3_3_28_2
  doi: 10.1007/s00251-003-0594-5
– ident: e_1_3_3_44_2
  doi: 10.1182/blood-2002-10-3065
– reference: 18090276 - AIDS. 2007 Nov 12;21(17):2283-91
– reference: 1655948 - J Exp Med. 1991 Oct 1;174(4):915-24
– reference: 8089491 - J Immunol. 1994 Oct 1;153(7):3135-40
– reference: 20519510 - J Biol Chem. 2010 Aug 6;285(32):24404-11
– reference: 18417030 - Curr HIV/AIDS Rep. 2008 Feb;5(1):13-9
– reference: 12942209 - Immunogenetics. 2003 Sep;55(6):362-9
– reference: 12663797 - J Virol. 2003 Apr;77(8):4911-27
– reference: 17906628 - Nat Immunol. 2007 Nov;8(11):1246-54
– reference: 12190181 - Am J Gastroenterol. 2002 Aug;97(8):2086-92
– reference: 9449724 - J Exp Med. 1998 Feb 2;187(3):439-44
– reference: 17041596 - Nat Med. 2006 Nov;12(11):1301-9
– reference: 19365081 - Blood. 2009 Jul 9;114(2):346-56
– reference: 12121660 - Immunity. 2002 Jun;16(6):779-90
– reference: 8228235 - J Immunol. 1993 Nov 15;151(10):5425-30
– reference: 19414738 - J Immunol. 2009 May 15;182(10):5891-7
– reference: 10861064 - J Immunol. 2000 Jul 1;165(1):292-6
– reference: 20016783 - PLoS One. 2009;4(12):e8194
– reference: 9036973 - J Immunol. 1997 Mar 1;158(5):2259-67
– reference: 10209514 - Clin Exp Immunol. 1999 Apr;116(1):115-20
– reference: 17336072 - Trends Microbiol. 2007 Apr;15(4):143-6
– reference: 17994023 - Nat Immunol. 2007 Dec;8(12):1372-9
– reference: 20154735 - Nat Rev Immunol. 2010 Mar;10(3):170-81
– reference: 10072482 - J Immunol. 1999 Mar 1;162(5):2457-61
– reference: 19596234 - Cell. 2009 Jul 10;138(1):30-50
– reference: 18256032 - J Biol Chem. 2008 Apr 25;283(17):11689-99
– reference: 8023143 - Science. 1994 Jul 8;265(5169):248-52
– reference: 17030951 - J Exp Med. 2006 Oct 30;203(11):2461-72
– reference: 20732847 - Eur Cytokine Netw. 2010 Sep;21(3):208-14
– reference: 11595300 - Immunol Lett. 2001 Nov 1;79(1-2):131-40
– reference: 16903920 - Immunol Rev. 2006 Aug;212:272-86
– reference: 21097698 - J Leukoc Biol. 2011 Apr;89(4):507-15
– reference: 11238678 - J Immunol. 2001 Mar 15;166(6):4244-53
– reference: 18424693 - J Immunol. 2008 May 1;180(9):5771-7
– reference: 21041726 - J Immunol. 2010 Dec 1;185(11):6599-607
– reference: 18401464 - PLoS Pathog. 2008 Feb;4(2):e1000004
– reference: 19534595 - J Infect Dis. 2009 Aug 1;200(3):448-52
– reference: 16014524 - Ann N Y Acad Sci. 2005 Jun;1050:97-107
– reference: 20208540 - Nat Med. 2010 Apr;16(4):452-9
– reference: 19748991 - J Immunol. 2009 Oct 1;183(7):4619-27
– reference: 17312176 - J Immunol. 2007 Mar 1;178(5):3265-71
– reference: 15271794 - Blood. 2004 Nov 15;104(10):3249-56
– reference: 18292493 - J Immunol. 2008 Mar 1;180(5):2752-6
– reference: 11121048 - Proc Natl Acad Sci U S A. 2000 Dec 19;97(26):14467-72
– reference: 16394019 - J Immunol. 2006 Jan 15;176(2):1274-80
– reference: 17656078 - Curr Opin Immunol. 2007 Aug;19(4):408-15
– reference: 12468426 - Blood. 2003 Apr 1;101(7):2514-20
SSID ssj0014464
Score 2.2043552
Snippet Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley...
T cell dysfunction in the presence of ongoing antigen exposure is a cardinal feature of chronic viral infections with persistent high viremia, including HIV-1....
SourceID pubmedcentral
proquest
pubmed
pascalfrancis
crossref
highwire
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 6586
SubjectTerms Biological and medical sciences
CD4-Positive T-Lymphocytes - immunology
Fundamental and applied biological sciences. Psychology
HIV Infections - immunology
HIV Infections - virology
HIV-1 - immunology
HIV-1 - physiology
Human immunodeficiency virus 1
Humans
Interferon-gamma - immunology
Interleukin-10 - blood
Interleukin-10 - immunology
Interleukin-2 Receptor alpha Subunit - immunology
Leukocytes, Mononuclear - immunology
Microbiology
Miscellaneous
Monocytes - immunology
Pathogenesis and Immunity
T-Lymphocytes, Regulatory - immunology
Up-Regulation
Virology
Title CD4+ CD25+ Regulatory T Cells Impair HIV-1-Specific CD4 T Cell Responses by Upregulating Interleukin-10 Production in Monocytes
URI http://jvi.asm.org/content/86/12/6586.abstract
https://www.ncbi.nlm.nih.gov/pubmed/22496237
https://www.proquest.com/docview/1016670261
https://www.proquest.com/docview/1113221422
https://pubmed.ncbi.nlm.nih.gov/PMC3393541
Volume 86
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELaqRUhcEG_CwspIcIpSEtfO4whdUHehHKBd9RYljrMEusmqD1blxj_iJzITJ2myW9DCJY0S20kzn8cz43kQ8kK4sfBUwi0R25EFXDKxogDmY6yY43opB50CY4fHH93RlB_PxKzX-9XyWlqv4r78sTOu5H-oCteArhgl-w-UbQaFC3AO9IUjUBiO16Lx8JAD6d6Yw0MmypNPurI87ptPzKGaz5eY_jfKFubo6ATUuLLafJpJE3vqFmjARy9ZtURJdHq-0ENoRwJ091Trb1kOfBRjChKdaxaNJMAMCrlZVS6IV8VbjJ9rW-zfX-j9_UpiNz_3txaIU53IYIyekGrdIK3IT0tD7qQ4KzbwFvWND9FFK6TIHPfbpgv0AaldrFqhBMBxZ3ox0hwYE5yiGNdm0VW27AqKrMVwQYByW4u3K3TJ5KsLA8Ngh-OTo74NGp9jVRy-k3_70rrYeCuWehLzQ-gdlr1DDCa_wUAxYbV9qNq3AuWa1_np8Y_VoRbMf9V-dlcIqhNTo19utISpmeqaKruUnsu-uy1haHKH3K7ITF9rSN4lPZXfIzd1XdPNffIT4EVNirCEny0o6YSWoKQalLQLSoq9dAvagJLGG9oGJe2Ckm5BSbOcNqB8QKbv3k6GI6uq9WFJ7vGV5XMJkrOMEk_EDmoFji29KB4oFsEyEYg0ddNE-bFnS0wajOVMgmggfCmSVCgvHTwke3mRq8eESjsdCA7HQAmeBCJwE1_GvgLVXWCxBIOY9ccPZZUIH-uxzMNdhDbIy6b1uU4A84d2-zUdw2h5Fn79noW-GzosRIga5KBD2mYo5to4M2yDPK9pHQKDx127KFfFeln6YLoemkr-0sZBoxKacw3ySONj-wTGA9BxPIN4HeQ0DTDBfPdOnn0pE80PMG6fO0-u-Qn2ya3tLH9K9laLtXoGIvsqPihnyW-IE-Wk
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=CD4+%2B+CD25+%2B+Regulatory+T+Cells+Impair+HIV-1-Specific+CD4+T+Cell+Responses+by+Upregulating+Interleukin-10+Production+in+Monocytes&rft.jtitle=Journal+of+virology&rft.au=Kwon%2C+Douglas+S.&rft.au=Angin%2C+Mathieu&rft.au=Hongo%2C+Tomoyuki&rft.au=Law%2C+Kenneth+M.&rft.date=2012-06-01&rft.issn=0022-538X&rft.eissn=1098-5514&rft.volume=86&rft.issue=12&rft.spage=6586&rft.epage=6594&rft_id=info:doi/10.1128%2FJVI.06251-11&rft.externalDBID=n%2Fa&rft.externalDocID=10_1128_JVI_06251_11
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-538X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-538X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-538X&client=summon